PCI gains ground for left main and multivessel disease in new European Society of Cardiology revascularization guidelines

www.theheart.org reports;

In a first for the European Society of Cardiology (ESC), a new task force report on myocardial revascularization released on the first day of the society’s annual meeting was jointly written with the European Association for Cardiothoracic Surgery (EACTS), and, among other things, concludes that in certain settings Percutaneous Coronary Intervention can reasonably be considered as a treatment for both left main and three-vessel disease.

At the core of the new report is the role of the “heart team,” in which an interventionalist, a surgeon, and a general cardiologist are all involved in the decision-making for patients seeking treatment for coronary disease.

To read the full article, click here.

Source: www.theheart.org